loadpatents
name:-0.024090051651001
name:-0.010756015777588
name:-0.00062012672424316
Laliberte; Sebastien Patent Filings

Laliberte; Sebastien

Patent Applications and Registrations

Patent applications and USPTO patent grants for Laliberte; Sebastien.The latest application filed is for "renin inhibitors".

Company Profile
0.10.18
  • Laliberte; Sebastien - St. Lazare N/A CA
  • Laliberte; Sebastien - Vaudreuil-Dorion CA
  • Laliberte; Sebastien - Saint-Lazare CA
  • Laliberte; Sebastien - Ile-Perrot CA
  • Laliberte; Sebastien - Vaudreui-Dorion CA
  • Laliberte; Sebastien - Kirkland CA
  • Laliberte; Sebastien - Lle Perrot CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
3,4-substituted piperidine derivatives as renin inhibitors
Grant 8,889,714 - Chen , et al. November 18, 2
2014-11-18
Case of renin inhibitors
Grant 8,343,968 - Wu , et al. January 1, 2
2013-01-01
Renin Inhibitors
App 20120190701 - Chen; Austin Chih-Yu ;   et al.
2012-07-26
Renin Inhibitors
App 20120035214 - McKay; Daniel J. ;   et al.
2012-02-09
Renin inhibitors
Grant 8,076,359 - Dube , et al. December 13, 2
2011-12-13
Renin Inhibitors
App 20110237622 - Chen; Austin Chih-Yu ;   et al.
2011-09-29
3,4-substituted Piperidine Derivatives As Renin Inhibitors
App 20110152316 - Chen; Austin Chih-Yu ;   et al.
2011-06-23
Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
Grant 7,960,409 - Grimm , et al. June 14, 2
2011-06-14
3,4-substituted Piperidine Derivatives As Renin Inhibitors
App 20110053940 - Chen; Austin Chih-Yu ;   et al.
2011-03-03
Novel Case Of Renin Inhibitors
App 20100120859 - Wu; Tom Yao-Hsiang ;   et al.
2010-05-13
Renin Inhibitors
App 20100063091 - Dube; Daniel ;   et al.
2010-03-11
Novel Pharmaceutical Compounds
App 20090227638 - Blouin; Marc ;   et al.
2009-09-10
Pharmaceutical compounds
Grant 7,553,973 - Blouin , et al. June 30, 2
2009-06-30
Novel pharmaceutical compounds
App 20090030048 - Blouin; Marc ;   et al.
2009-01-29
7-(1,3-thiazol-2-YL)thio-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
Grant 7,439,260 - Gareau , et al. October 21, 2
2008-10-21
Novel pharmaceutical compounds
App 20080188521 - Grimm; Erich L. ;   et al.
2008-08-07
Novel pharmaceutical compounds
App 20070149579 - Blouin; Marc ;   et al.
2007-06-28
7-(1,3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
App 20060116406 - Gareau; Yves ;   et al.
2006-06-01
Use of phosphodiesterase-4 inhibitors as enhancers of cognition
App 20060040981 - Dube; Daniel ;   et al.
2006-02-23
Alkyne-aryl phosphodiesterase-4 inhibitors
App 20050070569 - Guay, Daniel ;   et al.
2005-03-31
Tri-aryl-substituted-ethane PDE4 inhibitors
Grant 6,841,564 - Freisen , et al. January 11, 2
2005-01-11
Alkyne-aryl phosphodiesterase-4 inhibitors
Grant 6,743,802 - Guay , et al. June 1, 2
2004-06-01
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
Grant 6,677,351 - Li , et al. January 13, 2
2004-01-13
Alkyne-aryl phosphodiesterase-4 inhibitors
App 20030114478 - Guay, Daniel ;   et al.
2003-06-19
1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
App 20030096829 - Li, Chun ;   et al.
2003-05-22
Tri-aryl-substituted-ethane PDE4 inhibitors
App 20020173661 - Freisen, Richard ;   et al.
2002-11-21
Tri-aryl-substituted-ethane PDE4 inhibitors
App 20020013347 - Freisen, Richard ;   et al.
2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed